Want to know more about NHS National Framework Agreement for the Supply of Generic Pharmaceuticals - Interim 1 2020? Create and verify your free account to access full information.Create your free account

๐Ÿ“‘NHS National Framework Agreement for the Supply of Generic Pharmaceuticals - Interim 1 2020

Procurement process summary

This process is to purchase NHS National Framework Agreement for the Supply of Generic Pharmaceuticals - Interim 1 2020.

This contract was awarded by ๐Ÿ‡ฌ๐Ÿ‡ง NHS England for an amount of GBP 5,890,000 to 1 supplier. It was published on 2020-05-07 through open

Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.

Buying entity๐Ÿ‡ฌ๐Ÿ‡ง NHS England Buying unitnot reported Publication date2020-05-07 Contest statusnot reported DescriptionNHS national framework agreement for the supply of generic pharmaceuticals -- Interim 1 2020.Offer reference number: CM/PHG/20/5589Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months).Potential periods of call-offs under the framework agreementHospital Only Products:DLS/DNE/DNW 1 August 2020 to 31 July 2021 (12 months),DLN/DCE/DSW 1 August 2020 to 31 July 2021 (12 months).Products on the framework include (but are not limited to):-- Darunavir-- Disodium Pamidronate-- Doxorubicin-- Epirubicin-- Ethambutol-- Etoposide-- Glycopyrronium Bromide-- Ibuprofen-- Irinotecan-- Lopinavir/Ritonavir-- Milrinone-- Posaconazole-- Ritonavir-- Salbutamol-- Tramadol-- Vancomycin.Details of presentation sizes and volumes are within the tender document set.

Awards

This award was granted to Medac Pharma LLP by NHS England for an amount of GBP 5,890,000. The procurement process was conducted through open for the category of goods. This is award number 6.

This contract has multiple awards. This is award number 6. View other awards for this contract

SupplierAmountAward number
๐Ÿ‡ฌ๐Ÿ‡ง Medac Pharma LLPGBP 5,890,0006

Market context and opportunities

The execution of this contract allows the entity NHS England to fulfill its public service objectives efficiently.

The open purchase modality ensures that the process is transparent and compliant with regulations.

Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.

This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.

Additional data

Contract NumberUK_ocds-70d2nz-2a0fafc2-3b23-4dd7-977b-a201d9330afd-award-6Publication date2020-05-07Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reported

Data sources

Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.

Published byOpentender.eu
Countries231
LicenseCC BY-NC-SA 4.0
Year range2003 - 2025
Update statusNot updated (2025-01-01)
OpenTender obtains the information from the UK portal Contract Finder.